Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Fidelity Blue Chip Value ETF (FBCV) belongs to the Uncategorized Equities segment. Columbia Research Enhanced Value ETF (REVS) is part of the US Large Cap Value segment. FBCV's top 3 sector exposures are Financials, Industrials and Information Technology. In contrast, REVS's top sector exposures are Financials, Health Care and Industrials. FBCV is more expensive with a Total Expense Ratio (TER) of 0.57%, versus 0.19% for REVS. FBCV is up 2.58% year-to-date (YTD) with +$13M in YTD flows. REVS performs worse with 1.07% YTD performance, and +$73M in YTD flows. Run a side-by-side ETF comparison of FBCV and REVS below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FBCV REVS | -2.68%-3.46% | +3.39%+0.96% | +2.58%+1.07% | +17.66%+16.58% | +47.92%+57.50% | +53.31%+69.28% |
| Flows | FBCV REVS | -$20M+$4M | +$17M+$76M | +$13M+$73M | +$15M+$136M | -$10M+$171M | +$56M+$192M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FBCV REVS | +10.66%+11.19% | +13.95%+15.90% | +11.84%+13.30% | +13.57%+15.12% |
| Max drawdown | FBCV REVS | -5.11%-5.76% | -10.04%-12.32% | -14.17%-16.16% | -15.31%-17.78% |
| Max drawdown duration | FBCV REVS | 37d35d | 43d46d | 263d211d | 607d448d |
FBCV | REVS | |
Last sale 3/17/2026 at 7:59 PM | $36.55 | $28.74 |
| Previous close 03/17/2026 | $36.28 | $28.57 |
| Consolidated volume 03/17/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
FBCV | REVS | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
FBCV | REVS | |
|---|---|---|
| Last price | $36.55 | $28.74 |
| 1D performance | +0.74% | +0.60% |
| AuM | $159.76 M | $210.34 M |
| E/R | 0.57% | 0.19% |
FBCV | REVS | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Fidelity | Columbia Threadneedle Investments |
| Benchmark | - | Beta Advantage Research Enhanced U.S. Value Index |
| N° of holdings | 484 | 281 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 2, 2020 | September 25, 2019 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
